Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Department of Genetics, Pawinskiego 5A, 02106 Warsaw, Poland.
Department of Biomedical Science, University of Sheffield, Sheffield S10 2TN, UK.
Dis Model Mech. 2019 Jan 28;12(1):dmm036830. doi: 10.1242/dmm.036830.
Chorea-acanthocytosis (ChAc) is a rare neurodegenerative disease associated with mutations in the human gene. The mechanism of ChAc pathogenesis is unclear. A simple yeast model was used to investigate the function of the single yeast VSP13 orthologue, Vps13. Vps13, like human VPS13A, is involved in vesicular protein transport, actin cytoskeleton organisation and phospholipid metabolism. A newly identified phenotype of the Δ mutant, sodium dodecyl sulphate (SDS) hypersensitivity, was used to screen a yeast genomic library for multicopy suppressors. A fragment of the gene, encoding Myo3-N (the N-terminal part of myosin, a protein involved in the actin cytoskeleton and in endocytosis), was isolated. Myo3-N protein contains a motor head domain and a linker. The linker contains IQ motifs that mediate the binding of calmodulin, a negative regulator of myosin function. Amino acid substitutions that disrupt the interaction of Myo3-N with calmodulin resulted in the loss of Δ suppression. Production of Myo3-N downregulated the activity of calcineurin, a protein phosphatase regulated by calmodulin, and alleviated some defects in early endocytosis events. Importantly, ethylene glycol tetraacetic acid (EGTA), which sequesters calcium and thus downregulates calmodulin and calcineurin, was a potent suppressor of Δ. We propose that Myo3-N acts by sequestering calmodulin, downregulating calcineurin and increasing activity of Myo3, which is involved in endocytosis and, together with Osh2/3 proteins, functions in endoplasmic reticulum-plasma membrane contact sites. These results show that defects associated with Δ could be overcome, and point to a functional connection between Vps13 and calcium signalling as a possible target for chemical intervention in ChAc. Yeast ChAc models may uncover the underlying pathological mechanisms, and may also serve as a platform for drug testing.This article has an associated First Person interview with the first author of the paper.
棘红细胞增多症(ChAc)是一种罕见的神经退行性疾病,与人类 VPS13A 基因突变有关。ChAc 发病机制尚不清楚。本研究使用简单的酵母模型来研究单个酵母 Vsp13 同源物 Vps13 的功能。Vps13 像人类 VPS13A 一样,参与囊泡蛋白运输、肌动蛋白细胞骨架组织和磷脂代谢。Δ 突变体的一个新鉴定表型是十二烷基硫酸钠(SDS)敏感性,该表型被用于筛选酵母基因组文库中的多拷贝抑制子。鉴定到一个编码肌球蛋白 N 端(肌球蛋白参与肌动蛋白细胞骨架和内吞作用的蛋白)的基因片段。肌球蛋白 N 蛋白含有一个马达头部结构域和一个连接区。连接区含有 IQ 基序,介导钙调蛋白的结合,钙调蛋白是肌球蛋白功能的负调控因子。破坏 Myo3-N 与钙调蛋白相互作用的氨基酸取代导致 Δ 抑制作用丧失。Myo3-N 的表达降低了钙调蛋白调节的蛋白磷酸酶钙调神经磷酸酶的活性,并缓解了早期内吞作用事件的一些缺陷。重要的是,乙二胺四乙酸(EGTA)螯合钙,从而下调钙调蛋白和钙调神经磷酸酶,是Δ的有效抑制剂。我们提出,Myo3-N 通过螯合钙调蛋白,下调钙调神经磷酸酶并增加肌球蛋白的活性而起作用,肌球蛋白参与内吞作用,与 Osh2/3 蛋白一起,在内质网-质膜接触位点发挥作用。这些结果表明,可以克服与Δ相关的缺陷,并指出 Vps13 和钙信号之间的功能联系可能是 ChAc 化学干预的潜在靶点。酵母 ChAc 模型可能揭示潜在的病理机制,并可能成为药物测试的平台。本文有该论文第一作者的相关第一人称采访。